MCID: GRF002
MIFTS: 60

Graft Versus Host Disease malady

Rare diseases, Blood diseases categories

Summaries for Graft Versus Host Disease

About this section
Sources:
66Wikipedia, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
Wikipedia:66 Graft-versus-host disease (GVHD) is a common complication following an allogeneic tissue transplant. It... more...

MalaCards: Graft Versus Host Disease, also known as graft-versus-host disease, is related to acute graft versus host disease and leukemia. An important gene associated with Graft Versus Host Disease is IL2RA (interleukin 2 receptor, alpha), and among its related pathways are Immune response IL 12 signaling pathway and Hypertrophy Model. The compounds mycophenolate and lentinan have been mentioned in the context of this disorder. Affiliated tissues include t cells, bone and bone marrow, and related mouse phenotypes are digestive/alimentary and behavior/neurological.

Aliases & Classifications for Graft Versus Host Disease

About this section
Sources:
32LifeMap Discoveryā„¢, 46Novoseek
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Rare diseases
Anatomical: Blood diseases


Aliases & Descriptions:

graft versus host disease 32 46
graft-versus-host disease 46


Related Diseases for Graft Versus Host Disease

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Diseases in the Graft Versus Host Disease family:

Acute Graft Versus Host Disease Chronic Graft Versus Host Disease

Diseases related to Graft Versus Host Disease via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 255)
idRelated DiseaseScoreTop Affiliating Genes
1acute graft versus host disease32.1IL2RB, IL2RA, IL18, IFNG, TNF
2leukemia31.5IL2RB, IL2RA, IFNG, TNF
3dermatitis30.8IL18, IFNG
4severe combined immunodeficiency30.8IL2RB, IL2RA, IFNG
5pneumonia30.7IL2RB, TNF
6cutaneous t cell lymphoma30.7IL2RB, IL2RA, IFNG
7eosinophilia30.7IL2RB, IL2RA, IL18, IFNG
8lupus nephritis30.6IL2RA, IL18
9hepatitis b30.5IL2RA, IL18, IFNG
10uveitis30.5IL2RA, IFNG, TNF
11monocytic leukemia30.3IFNG, TNF
12t-cell large granular lymphocyte leukemia30.3IL2RB, IL18
13anaplastic large cell lymphoma30.3IL2RA, IL2RB
14atopic dermatitis30.3IL2RB, IL2RA, IL18, IFNG, TNF
15encephalomyelitis30.3TNF, IFNG
16systemic lupus erythematosus30.3TNF, IFNG, IL18, IL2RA, IL2RB
17b-cell chronic lymphocytic leukemia30.3IL2RB, IL2RA
18psoriasis30.2IL2RA, IL18, IFNG, TNF
19lymphopenia30.2IFNG, IL18, IL2RA, IL2RB
20melanoma30.1IL2RB, IFNG, TNF
21multiple sclerosis30.1TNF, IFNG, IL18, IL2RA, IL2RB
22chronic graft versus host disease11.6
23hematopoietic stem cell transplantation11.3
24endotheliitis10.8
25hepatitis10.7
26myeloid leukemia10.7
27scleroderma10.7
28bronchiolitis10.7
29bronchiolitis obliterans10.7
30acute myeloid leukemia10.6
31lymphoblastic leukemia10.6
32vaginitis10.6
33myelodysplastic syndromes10.6
34graft-versus-host disease, protection against10.6
35acute leukemia10.5
36aplastic anemia10.5
37cytomegalovirus infection10.5
38pure red-cell aplasia10.5
39lichen planus10.5
40erythema multiforme10.5
41diarrhea10.5
42herpes simplex10.5
43engraftment syndrome10.5
44lichen sclerosus10.5
45bronchiolitis obliterans organizing pneumonia10.4
46chronic myeloid leukemia10.4
47adult t-cell leukemia10.4
48pancytopenia10.4
49chronic lymphocytic leukemia10.4
50keratoconjunctivitis10.4

Graphical network of the top 20 diseases related to Graft Versus Host Disease:



Diseases related to graft versus host disease

Symptoms for Graft Versus Host Disease

About this section

Drugs & Therapeutics for Graft Versus Host Disease

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials, 32LifeMap Discoveryā„¢, 63UMLS, 42NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Graft Versus Host Disease

Drug clinical trials:

Search ClinicalTrials for Graft Versus Host Disease

Search NIH Clinical Center for Graft Versus Host Disease

Search CenterWatch for Graft Versus Host Disease

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Read about Graft Versus Host Disease cell therapies at LifeMap Discovery.

Genetic Tests for Graft Versus Host Disease

About this section

Anatomical Context for Graft Versus Host Disease

About this section
Sources:
32LifeMap Discoveryā„¢, 34MalaCards
See all sources

MalaCards organs/tissues related to Graft Versus Host Disease:

34
T cells, Bone, Bone marrow, Liver, Skin, B cells, Endothelial, Myeloid, Eye, Lung, Colon, Monocytes, Kidney, Testes, Tongue, Nk cells, Pancreas, Breast, Thyroid, Heart, Thymus, Whole blood, Lymph node, Salivary gland

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Graft Versus Host Disease:
id TissueAnatomical CompartmentCell Relevance
1 BoneBone MarrowBone Marrow Stromal Cells Potential therapeutic candidate

Animal Models for Graft Versus Host Disease or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Graft Versus Host Disease:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.4TNF, IFNG, IL18, IL2RA
2MP:00053868.0IL2RB, IL18, IFNG, TNF
3MP:00107717.7TNF, IFNG, IL18, IL2RB
4MP:00053977.7IL2RB, IL2RA, IL18, IFNG, TNF
5MP:00053877.6TNF, IFNG, IL18, IL2RA, IL2RB
6MP:00053787.6IL2RB, IL2RA, IL18, IFNG, TNF
7MP:00107687.4IL2RB, IL2RA, IL18, IFNG, TNF

Publications for Graft Versus Host Disease

About this section
Sources:
53PubMed
See all sources

Articles related to Graft Versus Host Disease:

(show top 50)    (show all 1638)
idTitleAuthorsYear
1
Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients. (24127668)
2013
2
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease. (23242592)
2013
3
Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease. (24304375)
2013
4
Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. (23480177)
2013
5
Isomorphic sclerotic-type cutaneous chronic graft-versus-host disease: report and review of chronic graft-versus-host disease in a cutaneous immunocompromised district. (24318412)
2013
6
Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. (23871780)
2013
7
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target. (23694952)
2013
8
Successful response to infliximab of recurrent pericardial graft versus host disease in a pediatric patient. (22580769)
2013
9
The use of novel Therakosa8c CellexAr for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. (23961954)
2013
10
Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease. (23070118)
2012
11
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of I+-defensins. (22535662)
2012
12
Erythema ab igne as a differential diagnosis of chronic graft versus host disease (GVHD). (22834457)
2012
13
Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease. (21369795)
2012
14
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. (22371885)
2012
15
Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis. (19786111)
2010
16
Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases. (20514533)
2010
17
Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. (19857590)
2010
18
Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. (20042727)
2010
19
HBs seroconversion in a patient with acute hepatitis B treated with entecavir during immunosuppression against severe bronchiolitis obliterans in the course of chronic graft versus host disease. (20403727)
2010
20
Possible role of engraftment syndrome and autologous graft-versus-host disease in myelodysplastic syndrome after autologous stem cell transplantations: retrospective analysis and review of the literature. (20371446)
2010
21
Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. (19925878)
2010
22
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease. (20217287)
2010
23
Pathogenetic role of tissue factor in endothelial-injury in graft-versus-host disease]. (19954621)
2009
24
Acute graft-versus-host disease: from the bench to the bedside. (19713461)
2009
25
Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis. (19896085)
2009
26
Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study. (19589490)
2009
27
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. (19508292)
2009
28
Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. (18209723)
2008
29
Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. (19041064)
2008
30
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. (18241274)
2008
31
Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia. (17972946)
2008
32
Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. (17429441)
2007
33
Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. (17318079)
2007
34
Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. (17878478)
2007
35
Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit? (16474408)
2006
36
Diagnosis and treatment of chronic graft-versus-host disease. (16412791)
2006
37
A case of severe sclerodermatous chronic graft-versus-host disease: exposure to cement containing abundant silica may have been a relevant factor in scleroderma-like skin changes. (16043910)
2005
38
Regulation of OX40 gene expression in graft-versus-host disease. (15808546)
2005
39
Protective conditioning for acute graft-versus-host disease. (16192477)
2005
40
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease. (15744237)
2005
41
Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation. (15167618)
2004
42
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand. (14993881)
2004
43
TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. (12734353)
2003
44
Roles of interleukin-10 in acute graft-versus-host disease and graft rejection. (12875717)
2003
45
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. (10779417)
2000
46
Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. (10887333)
2000
47
Anti-mitosin antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. (9156273)
1997
48
Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. (8640164)
1996
49
Antigenaemia during acute graft versus host disease. (7745106)
1995
50
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. (8049447)
1994

Variations for Graft Versus Host Disease

About this section

Expression for genes affiliated with Graft Versus Host Disease

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Graft Versus Host Disease

Search GEO for disease gene expression data for Graft Versus Host Disease.

Pathways for genes affiliated with Graft Versus Host Disease

About this section
Sources:
51PathCards, 61Thomson Reuters, 39NCBI BioSystems Database, 31KEGG, 54QIAGEN, 58SinoBiological, 56Reactome, 55R&D Systems
See all sources

Pathways related to Graft Versus Host Disease according to GeneCards/GeneDecks:

(show top 50)    (show all 53)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.5IL2RA, IFNG
29.4IL18, IFNG
3
Show member pathways
9.4IL18, IFNG
49.4TNF, IL2RA
59.3TNF, IFNG
69.3TNF, IFNG
79.3IFNG, TNF
8
Show member pathways
Transcription NF kB signaling pathway61
Immune response Toll like receptor TLR ligands and common TLR signaling pathway leading to cell proinflammatory response61
9.3IFNG, TNF
9
Show member pathways
9.3IFNG, TNF
109.3IFNG, TNF
119.3IFNG, TNF
12
Show member pathways
Immune response MIF in innate immunity response61
9.3TNF, IFNG
13
Show member pathways
9.3IFNG, TNF
14
Show member pathways
thioredoxin pathway39
9.3TNF, IFNG
159.3IFNG, TNF
169.3IL18, TNF
17
Show member pathways
9.3IL18, TNF
189.3TNF, IL18
19
Show member pathways
Immune response IL 22 signaling pathway61
G protein signaling N RAS regulation pathway61
9.2IL2RB, IL2RA
20
Show member pathways
Immune response IL 3 activation and signaling pathway61
9.2IL2RA, IL2RB
21
Show member pathways
IL2 signaling events mediated by STAT539
9.2IL2RB, IL2RA
229.0IFNG, IL18, IL2RA
23
Show member pathways
Calcium signaling in the CD4+ TCR pathway39
8.9TNF, IFNG, IL2RA
248.8TNF, IFNG, IL18
258.8IL18, IFNG, TNF
268.8TNF, IFNG, IL18
278.8IL18, IFNG, TNF
28
Show member pathways
IL27-mediated signaling events39
8.8TNF, IFNG, IL18
298.8TNF, IFNG, IL18
30
Show member pathways
8.8IL18, IFNG, TNF
318.8TNF, IFNG, IL18
32
Show member pathways
IL23-mediated signaling events39
Immune response IL 10 signaling pathway61
Angiopoietin receptor Tie2-mediated signaling39
Development PDGF signaling via STATs and NF kB61
Development Angiopoietin Tie2 signaling61
8.8IL18, IFNG, TNF
33
Show member pathways
IL-2 Signaling pathway39
8.7IL2RB, IL2RA, IFNG
34
Show member pathways
Type III interferon signaling39
8.7IFNG, IL2RA, IL2RB
358.7IL2RB, IL2RA, IFNG
36
Show member pathways
8.7IL2RB, IL2RA, IL18
37
Show member pathways
IL-9 Signaling Pathway39
Development Thrombopoietin regulated cell processes61
IL-7 Signaling Pathway39
Immune response IL 9 signaling pathway61
8.6IL2RB, IL2RA, TNF
388.6TNF, IL2RA, IL2RB
39
Show member pathways
8.4IL2RA, IL18, IFNG, TNF
40
Show member pathways
Immune response IL 12 induced IFN gamma production61
8.2IL2RB, IL2RA, IL18, IFNG
41
Show member pathways
8.2IL2RB, IL2RA, IL18, IFNG
42
Show member pathways
8.1IL2RB, IL2RA, IFNG, TNF
43
Show member pathways
Ras signaling in the CD4+ TCR pathway39
8.1TNF, IFNG, IL2RA, IL2RB
44
Show member pathways
8.1TNF, IFNG, IL2RA, IL2RB
45
Show member pathways
8.1TNF, IL18, IL2RA, IL2RB
46
Show member pathways
8.1TNF, IL18, IL2RA, IL2RB
47
Show member pathways
8.1IL2RB, IL2RA, IL18, TNF
48
Show member pathways
7.5IL2RB, IL2RA, IL18, IFNG, TNF
49
Show member pathways
7.5TNF, IFNG, IL18, IL2RA, IL2RB
50
Show member pathways
7.5TNF, IFNG, IL18, IL2RA, IL2RB

Compounds for genes affiliated with Graft Versus Host Disease

About this section
Sources:
46Novoseek, 62Tocris Bioscience, 30IUPHAR, 12DrugBank, 52PharmGKB, 3BitterDB, 25HMDB
See all sources

Compounds related to Graft Versus Host Disease according to GeneCards/GeneDecks:

(show top 50)    (show all 126)
idCompoundScoreTop Affiliating Genes
1mycophenolate469.5IL2RA, IL2RB
2lentinan469.5IL2RA, IL2RB
3tuberculin469.4IL2RA, IFNG, IL18
4thymoglobulin469.3IL2RB, IL2RA
5gold sodium thiomalate469.3IFNG, IL2RA, TNF
6il-12469.2TNF, IL18, IFNG
7indoleamine469.2IL18, TNF, IFNG
8imiquimod46 62 30 1212.2TNF, IFNG, IL18
9gm-csf46 3010.1TNF, IFNG, IL18
10polyinosinic-polycytidylic acid469.1IFNG, TNF, IL18
11denileukin diftitox46 52 1211.1IL2RA, IL2RB
12poly(i-c)469.1TNF, IFNG, IL18
13tarc469.0TNF, IL18, IFNG
14levamisole46 1210.0IL2RB, IL2RA, IL18
15interferon gamma469.0TNF, IFNG
16chloroquine46 3 52 30 1213.0IL2RA, TNF, IL18
17ccl346 3010.0IL18, IFNG, TNF
18pdtc469.0TNF, IFNG, IL18
19atorvastatin46 52 30 25 1212.9TNF, IL18, IL2RA
20simvastatin46 52 62 30 25 1213.8TNF, IFNG, IL18
21natalizumab46 129.8IFNG, TNF, IL18, IL2RA
22thalidomide46 52 62 1211.7IL2RA, IL18, IFNG, TNF
23indomethacin46 30 62 1211.7TNF, IFNG, IL2RA, IL18
24con a468.6IL2RB, IFNG, IL18, IL2RA
25ifn-alpha468.6IFNG, IL18, IL2RA, IL2RB
26okt3468.5IFNG, TNF, IL2RB, IL2RA
272,5-oligoadenylate468.5TNF, IL2RB, IL2RA, IFNG
28ivig468.5IFNG, TNF, IL2RB, IL2RA
29rapamycin468.4IL2RA, IL18, IFNG, IL2RB
30etanercept46 52 1210.4TNF, IFNG, IL18, IL2RB
31methotrexate52 46 1210.4IL2RB, IL2RA, TNF, IL18
32n acetylcysteine468.4IL18, IL2RA, IL2RB, TNF
33endotoxin468.4TNF, IFNG, IL2RB, IL18
34genistein46 30 62 3 25 1213.3IFNG, IL2RA, IL2RB, TNF
35cycloheximide468.1IFNG, IL18, IL2RB, TNF
36il 10468.0TNF, IL2RA, IL2RB, IFNG, IL18
37mycophenolate mofetil46 52 1210.0TNF, IFNG, IL18, IL2RA, IL2RB
38infliximab46 52 1210.0IL2RB, IL18, IFNG, TNF, IL2RA
39pentoxifylline46 129.0TNF, IFNG, IL2RB, IL2RA, IL18
40neopterin468.0TNF, IL2RB, IFNG, IL18, IL2RA
41prednisolone46 30 1210.0IL2RA, IFNG, IL2RB, IL18, TNF
42ionomycin468.0IFNG, IL18, IL2RA, TNF, IL2RB
43tacrolimus46 52 1210.0IL2RB, IL2RA, TNF, IL18, IFNG
44rantes468.0TNF, IL2RB, IL18, IFNG, IL2RA
45histamine46 30 259.9IFNG, IL2RB, IL2RA, IL18, TNF
46cyclosporin a46 30 629.9IL18, IL2RB, IFNG, TNF, IL2RA
47pge2467.9IL18, TNF, IFNG, IL2RA, IL2RB
48thymidine46 258.9IL18, IFNG, IL2RA, IL2RB, TNF
49dexamethasone46 52 30 1210.9TNF, IFNG, IL2RB, IL18, IL2RA
50vegf467.9IL2RB, TNF, IFNG, IL18, IL2RA

GO Terms for genes affiliated with Graft Versus Host Disease

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Graft Versus Host Disease according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:0098978.1IL2RB, IL2RA, IFNG, TNF

Biological processes related to Graft Versus Host Disease according to GeneCards/GeneDecks:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of activated T cell proliferationGO:0421049.8IL18, IL2RA
2positive regulation of vitamin D biosynthetic processGO:0605579.7IFNG, TNF
3positive regulation of calcidiol 1-monooxygenase activityGO:0605599.7IFNG, TNF
4positive regulation of chemokine biosynthetic processGO:0450809.6IFNG, TNF
5positive regulation of membrane protein ectodomain proteolysisGO:0510449.6IFNG, TNF
6negative regulation of growth of symbiont in hostGO:0441309.6TNF, IFNG
7positive regulation of NF-kappaB import into nucleusGO:0423469.6IL18, TNF
8positive regulation of osteoclast differentiationGO:0456729.6IFNG, TNF
9protein import into nucleus, translocationGO:0000609.6IFNG, TNF
10lipopolysaccharide-mediated signaling pathwayGO:0316639.6TNF, IL18
11positive regulation of nitric oxide biosynthetic processGO:0454299.5IFNG, TNF
12cellular response to organic cyclic compoundGO:0714079.5IL18, TNF
13extrinsic apoptotic signaling pathwayGO:0971919.5TNF, IFNG
14positive regulation of interferon-gamma productionGO:0327299.4IL18, TNF
15humoral immune responseGO:0069599.4TNF, IFNG
16response to virusGO:0096159.3IFNG, TNF
17MAPK cascadeGO:0001659.2TNF, IL18
18regulation of insulin secretionGO:0507969.0IFNG, TNF
19apoptotic processGO:0069158.9IL2RA, IFNG, TNF

Molecular functions related to Graft Versus Host Disease according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1interleukin-2 receptor activityGO:0049119.1IL2RB, IL2RA
2interleukin-2 bindingGO:0199768.9IL2RB, IL2RA
3cytokine activityGO:0051258.8IL18, IFNG, TNF

Products for genes affiliated with Graft Versus Host Disease

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Graft Versus Host Disease

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet